The Journal of Pathology, Microbiology and Immunology (PMI Journal) invites submissions for a new focus issue on innovative pathology research for translating disease mechanisms into clinical therapauetic strategies.
Pathology is central to understanding disease mechanisms and translating biological discoveries into effective therapies. Advances in molecular pathology, genomics, multi-omics, artificial intelligence, and computational biology have transformed our understanding of disease, revealing novel biomarkers, therapeutic targets, and precision treatment strategies.
Emerging technologies, including single-cell and spatial omics, CRISPR-based models, liquid biopsies, and AI-assisted image analysis, provide unprecedented insights into disease pathogenesis and accelerate the improvement of personalized therapeutics.
This Special Issue aims to showcase innovative research that bridges pathological mechanisms and therapeutic development.
Submissions may address, but are not limited to:
• Precision oncology and the tumor microenvironment
• Epigenetic mechanisms and gene therapies
• Multi-omics biomarker discovery
• CRISPR-based therapeutic strategies
• Spatial omics and disease mapping
• AI-enabled digital pathology
• Liquid biopsies for early detection and disease monitoring
• Organoid models for disease mechanisms and drug discovery
• Microbiome-host interactions in disease pathogenesis
• Tumor-immune interactions and cancer immunotherapy
All contributions will be subject to a single-blinded peer-review process and acceptance relies with the journal’s Editors-in-Chief.
Guest Editors: Ricardo Carreno Aguilera [Lead Editor], Nadir Ibrahimoglu & Muhammad Suleman Memon
Submission deadline: 30.12.2026
